1 |
Karande, P., Arora, A., Pham, T. K., Stevens, D., Wojicki, A. and Mitragotri, S. (2009) Transcutaneous immunization using common chemicals. J. Control. Release 138, 134-140.
DOI
ScienceOn
|
2 |
Bos, J. D. and Meinardi, M. M. (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9, 165-169.
DOI
ScienceOn
|
3 |
Brown, M. B., Traynor, M. J., Martin, G. P. and Akomeah, F. K. (2008) Transdermal drug delivery systems: skin perturbation devices. Methods Mol. Biol. 437, 119-139.
DOI
ScienceOn
|
4 |
Sieg, A. and Wascotte, V. (2009) Diagnostic and therapeutic applications of iontophoresis. J. Drug Target. 17, 690-700.
DOI
ScienceOn
|
5 |
Batheja, P., Thakur, R. and Michniak, B. (2006) Transdermal iontophoresis. Expert Opin. Drug Deliv. 3, 127-138.
DOI
ScienceOn
|
6 |
Charoo, N. A., Rahman, Z., Repka, M. A. and Murthy, S. N. (2010) Electroporation: an avenue for transdermal drug delivery. Curr. Drug Deliv. 7, 125-136.
DOI
ScienceOn
|
7 |
Chen, X., Shah, D., Kositratna, G., Manstein, D., Anderson, R. R. and Wu, M. X. (2012) Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J. Control. Release 159, 43-51.
DOI
ScienceOn
|
8 |
Naohiro, S., Yoshiki, T., Takafumi N., Hideo, H., Fukumi, F. and Masahiro T. (2000) Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc. Natl. Acad. Sci. U.S.A. 97, 371-376.
DOI
|
9 |
Ochoa, M. T., Loncaric, A., Krutzik, S. R., Becker, T. C. and Modlin, R. L. (2008) "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J. Invest. Dermatol. 128, 2225-2231.
DOI
ScienceOn
|
10 |
Toebak, M. J., Gibbs, S., Bruynzeel, D. P., Scheper, R. J. and Rustemeyer, T. (2009) Dendritic cells: biology of the skin. Contact Dermatitis 60, 2-20.
DOI
ScienceOn
|
11 |
Romani, N., Clausen, B. E. and Stoitzner, P. (2010) Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234, 120-141.
DOI
ScienceOn
|
12 |
Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G. and Lowes, M. A. (2007) Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 117, 2517-2525.
DOI
ScienceOn
|
13 |
Nestle, F. O., Zheng, X. G., Thompson, C. B., Turka, L. A. and Nickoloff, B. J. (1993) Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151, 6535-6545.
|
14 |
Klechevsky, E., Liu, M., Morita, R., Banchereau, R., Thompson-Snipes, L., Palucka, A. K., Ueno, H. and Banchereau, J. (2009) Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum. Immunol. 70, 281-288.
DOI
ScienceOn
|
15 |
Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R. S., Wojtasiak, M., Shortman, K., Carbone, F. R., Brooks, A. G. and Heath, W. R. (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10, 488-495.
DOI
ScienceOn
|
16 |
Clark, R. A. (2010) Skin-resident T cells: the ups and downs of on site immunity. J. Invest. Dermatol. 130, 362-370.
DOI
ScienceOn
|
17 |
Bal, S. M., Ding, Z., van Riet, E., Jiskoot, W. and Bouwstra, J. A. (2010) Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J. Control Release 148, 266-282.
DOI
ScienceOn
|
18 |
Kirschner, N. and Brandner, J. M. (2012) Barriers and more: functions of tight junction proteins in the skin. Ann. N. Y. Acad. Sci. 1257, 158-166.
DOI
ScienceOn
|
19 |
Karande, P. and Mitragotri, S. (2010) Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies. Annu. Rev. Chem. Biomol. Eng. 1, 175-201.
DOI
ScienceOn
|
20 |
Glenn, G. M., Taylor, D. N., Li, X., Frankel, S., Montemarano, A. and Alving, C. R. (2000) Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. 6, 1403-1406.
DOI
ScienceOn
|
21 |
Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., Caux, C., Lebecque, S. and Saeland, S. (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81.
DOI
ScienceOn
|
22 |
Hirobe, S., Matsuo, K., Quan, Y. S., Kamiyama, F., Morito, H., Asada, H., Takaya, Y., Mukai, Y., Okada, N. and Nakagawa, S. (2012) Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria. Vaccine 30, 1847-1854.
DOI
ScienceOn
|
23 |
Joshi, N., Duhan, V., Lingwal, N., Bhaskar, S. and Upadhyay, P. (2012) Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells. PLoS One 7, e32067.
DOI
|
24 |
Glenn, G. M., Rao, M., Matyas, G. R. and Alving, C. R. (1998) Skin immunization made possible by cholera toxin. Nature 391, 851.
DOI
ScienceOn
|
25 |
Tomoka, T-N., Erika, T., Megumi, K. and Koichi, T. (2012) Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response. PLoS One 7, e47980.
DOI
|
26 |
Gupta, R. K. and Siber, G. R. (1994) Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 22, 53-63.
DOI
ScienceOn
|
27 |
Beignon, A. S., Briand, J. P., Muller, S. and Partidos, C. D. (2001) Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge. Immunology 102, 344-351.
DOI
|
28 |
Connell, T. D. (2007) Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins. Expert Rev. Vaccines 6, 821-834.
DOI
ScienceOn
|
29 |
Scharton-Kersten, T., Yu, Jm, Vassell, R., O'Hagan, D., Alving, C. R. and Glenn, G. M. (2000) Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immun. 68, 5306-5313.
DOI
ScienceOn
|
30 |
Olvera-Gomez, I., Hamilton, S. E., Xiao, Z., Guimaraes, C. P., Ploegh, H. L., Hogquist, K. A., Wang, L. and Jameson, S. C. (2012) Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc. Natl. Acad. Sci. U.S.A. 109, 2072-2077.
DOI
ScienceOn
|
31 |
Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J, and Narasimhan, B. (2009) Vaccine adjuvants: current challenges and future approaches. J. Pharm. Sci. 98, 1278-1316.
DOI
ScienceOn
|
32 |
Watabe, S., Xin, K. Q., Ihata, A., Liu, L. J., Honsho, A., Aoki, I., Hamajima, K., Wahren, B. and Okuda, K. (2001) Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19, 4434-4444.
DOI
ScienceOn
|
33 |
Vrdoljak, A., McGrath, M. G., Carey, J. B., Draper, S. J., Hill, A. V., O'Mahony, C., Crean, A. M. and Moore, A. C. (2012) Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J. Control. Release 159, 34-42.
DOI
ScienceOn
|
34 |
Polat, B. E., Hart, D., Langer, R. and Blankschtein, D. (2011) Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J. Control. Release 152, 330-348.
DOI
ScienceOn
|
35 |
Peachman, K. K., Rao, M., Alving, C. R., Burge, R., Leppla, S. H., Rao, V. B. and Matyas, G. R. (2006) Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect. Immun. 74, 794-797.
DOI
ScienceOn
|
36 |
Wang, J., Hu, J. H., Li, F. Q., Liu, G. Z., Zhu, Q. G., Liu, J. Y., Ma, H. J., Peng, C. and Si, F. G. (2007) Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex. Exp. Dermatol. 16, 724-729.
DOI
ScienceOn
|
37 |
Partidos, C. D., Beignon, A. S., Brown, F., Kramer, E., Briand, J. P. and Muller, S. (2002) Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination. J. Control. Release 85, 27-34.
DOI
ScienceOn
|
38 |
Beignon, A. S., Briand, J. P., Muller, S. and Partidos, C. D. (2002) Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus- specific CD4+ T cells. Immunology 105, 204-212.
DOI
ScienceOn
|
39 |
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A. and Banchereau, J. (1997) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony- stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90, 1458-1470.
|
40 |
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., Reiter, Y., Banchereau, J. and Ueno, H. (2008) Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497-510.
DOI
ScienceOn
|
41 |
Dubois, B., Massacrier, C., Vanbervliet, B., Fayette, J., Brière, F., Banchereau, J. and Caux, C. (1998) Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 161, 2223-2231.
|
42 |
Sixt, M., Kanazawa, N., Selg, M., Samson, T., Roos, G., Reinhardt, D. P., Pabst, R., Lutz, M. B. and Sorokin, L. (2005) The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19-29.
DOI
ScienceOn
|
43 |
Li, N., Peng, L. H., Chen, X., Nakagawa, S. and Gao, J. Q. (2011) Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine 29, 6179-6190.
DOI
ScienceOn
|
44 |
Combadiere, B. and Liard, C. (2011) Transcutaneous and intradermal vaccination. Hum. Vaccine 7, 811-827.
DOI
ScienceOn
|
45 |
Glenn, G. M., Scharton-Kersten, T., Vassell, R., Mallett, C. P., Hale, T. L. and Alving, C. R. (1998) Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J. Immunol. 161, 3211-3214.
|
46 |
Huang, Y., Park, Y. S., Moon, C., David, A. E., Chung, H. S. and Yang, V. C. (2010) Synthetic skin-permeable proteins enabling needleless immunization. Angew. Chem. Int. Ed. Engl. 49, 2724-2727.
DOI
ScienceOn
|
47 |
Slovin, S. F., Keding, S. J. and Ragupathi, G. (2005) Carbohydrate vaccines as immunotherapy for cancer. Immunol. Cell Biol. 83, 418-428.
DOI
ScienceOn
|
48 |
Brooks, N. A., Pouniotis, D. S., Tang, C. K., Apostolopoulos, V. and Pietersz, G. A. (2010) Cell-penetrating peptides: application in vaccine delivery. Biochim. Biophys. Acta 1805, 25-34.
|
49 |
Tarique, A. A., Kalsy, A., Arifuzzaman, M., Rollins, S. M., Charles, R. C., Leung, D. T., Harris, J. B., Larocque, R. C., Sheikh, A., Bhuiyan, M. S., Saksena, R., Clements, J. D., Calderwood, S. B., Qadri, F., Kovác, P. and Ryan, E. T. (2012) Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Clin. Vaccine Immunol. 19, 594-602.
DOI
|
50 |
Mawas, F., Peyre, M., Beignon, A. S., Frost, L., Del Giudice, G., Rappuoli, R., Muller, S., Sesardic, D. and Partidos, C. D. (2004) Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine. J. Infect. Dis. 190, 1177-1182.
DOI
ScienceOn
|
51 |
Ouerfelli, O., Warren, J. D., Wilson, R. M. and Danishefsky, S. J. (2005) Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities. Expert Rev. Vaccines 4, 677-685.
DOI
ScienceOn
|
52 |
Skountzou, I., Quan, F. S., Jacob, J., Compans, R. W. and Kang, S. M. (2006) Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24, 6110-6119.
DOI
ScienceOn
|
53 |
El-Ghorr, A. A., Williams, R. M., Heap, C. and Norval, M. (2000) Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice. FEMS Immunol. Med. Microbiol. 29, 255-261.
DOI
|
54 |
Scott, E. A., Stano, A., Gillard, M., Maio-Liu, A. C., Swartz, M. A. and Hubbell, J. A. (2012) Dendritic cell activation and T cell priming with adjuvant- and antigenloaded oxidation-sensitive polymersomes. Biomaterials 33, 6211-6219.
DOI
ScienceOn
|
55 |
Riminton, D. S., Kandasamy, R., Dravec, D., Basten, A. and Baxter, A. G. (2004) Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease. J. Immunol. 1, 302-309.
|
56 |
Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H. and Radsak, M. P. (2005) Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J. Immunol. 174, 2476-2480.
DOI
|
57 |
Weldon, W. C., Zarnitsyn, V. G., Esser, E. S., Taherbhai, M. T., Koutsonanos, D. G., Vassilieva, E. V., Skountzou, I., Prausnitz, M. R. and Compans, R. W. (2012). Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One 7, e41501.
DOI
ScienceOn
|
58 |
Chang, B. A., Cross, J. L., Najar, H. M. and Dutz, J. P. (2009) Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine 27, 5791-5799.
DOI
ScienceOn
|
59 |
Verthelyi, D. and Zeuner, R. A. (2003) Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24, 519-522.
DOI
ScienceOn
|
60 |
Kim, D., Kwon, H. J. and Lee, Y. (2011) Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA. BMB Rep. 44, 607-612.
과학기술학회마을
DOI
ScienceOn
|
61 |
Kim, D., Kwon, S., Ahn, C. S., Lee, Y., Choi, S. Y., Park, J., Kwon, H. Y. and Kwon, H. J. (2011) Adjuvant effect of liposome- encapsulated natural phosphodiester CpG-DNA. BMB Rep. 44, 758-763.
과학기술학회마을
DOI
ScienceOn
|
62 |
Cui, Z. and Sloat, B. R. (2006) Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid. Int. J. Pharm. 317, 187-191.
DOI
ScienceOn
|
63 |
Zhang, J., Shi, Z., Kong, F. K., Jex, E., Huang, Z., Watt, J. M., Van Kampen, K. R. and Tang, D. C. (2006) Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity. Infect. Immun. 74, 3607-3617.
DOI
ScienceOn
|
64 |
Mishra, D., Mishra, P. K., Dabadghao, S., Dubey, V., Nahar, M. and Jain, N. K. (2010) Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomedicine 6, 110-118.
DOI
ScienceOn
|
65 |
Benson, H. A. (2006) Transfersomes for transdermal drug delivery. Expert Opin. Drug Deliv. 3, 727-737.
DOI
|
66 |
Vyas, S. P., Singh, R. P., Jain, S., Mishra, V., Mahor, S., Singh, P., Gupta, P. N., Rawat, A. and Dubey, P. (2005) Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm. 296, 80-86.
DOI
ScienceOn
|
67 |
Boyer, C. and Zasadzinski, J. A. (2007) Multiple lipid compartments slow vesicle contents release in lipases and serum. ACS Nano 1, 176-182.
DOI
ScienceOn
|
68 |
Kim, Y. C., Ludovice, P. J. and Prausnitz, M. R. (2007) Transdermal delivery enhanced by magainin pore-forming peptide. J. Control. Release 122, 375-383.
DOI
ScienceOn
|
69 |
Himes, R., Lee, S., McMenigall, K. and Russell-Jones, G. (2011) The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination. Vaccine 29, 5393-5398.
DOI
ScienceOn
|
70 |
Diwan, M., Tafaghodi, M. and Samuel, J. (2002) Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J. Control. Release 85, 247-262.
DOI
ScienceOn
|
71 |
Slutter, B., Bal, S. M., Ding, Z., Jiskoot, W. and Bouwstra, J. A. (2011) Adjuvant effect of cationic liposomes and CpG depends on administration route. J. Control. Release. 154, 123-130.
DOI
ScienceOn
|
72 |
Ozaki, T., Yauchi, M., Xin, K. Q., Hirahara, F. and Okuda, K. (2005) Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant. Viral Immunol. 18, 373-380.
DOI
ScienceOn
|
73 |
Belyakov, I. M., Hammond, S. A., Ahlers, J. D., Glenn, G. M. and Berzofsky, J. A. (2004) Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113, 998-1007.
DOI
ScienceOn
|
74 |
Inoue, J. and Aramaki, Y. (2007) Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides. Vaccine 25, 1007-1013.
DOI
ScienceOn
|
75 |
Hickey, D. K., Aldwell, F. E., Tan, Z. Y., Bao, S. and Beagley, K. W. (2009) Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine. 27, 6983-6990.
DOI
ScienceOn
|
76 |
Hickey, D. K., Bao, S., Ikeda, L. T., Carey, A. J. and Beagley, K. W. (2005) Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF. Curr. Mol. Med. 5, 559-605.
|
77 |
Huang, C. M., Wang, C. C., Kawai, M., Barnes, S. and Elmets, C. A. (2006) Surfactant sodium lauryl sulfate enhances skin vaccination: molecular characterization via a novel technique using ultrafiltration capillaries and mass spectrometric proteomics. Mol. Cell. Proteomics 5, 523-532.
DOI
|